Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded encouraging discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying mechanisms of MSA. One avenue under investigation involves pharmacological interventions to modulate the function o